Dealings Round-Up
Director dealings: Two Playtech directors pick up shares in gaming supplier
Two of Playtech's non-executive directors picked up shares in the online gaming software supplier on Wednesday.
Director dealings: SysGroup CFO acquires stake
IT services and cloud hosting provider SysGroup revealed on Thursday that chief financial officer Martin Audcent had acquired 59,808 ordinary shares in the AIM-listed firm.
Director dealings: Non-Standard Finance director and spouse up stakes
Non-Standard Finance revealed on Wednesday that executive director Miles Cresswell-Turner had acquired 70,000 ordinary shares in the UK-based consumer finance company.
Director dealings: Ergomed founder ups stake
Ergomed revealed on Tuesday that executive chairman Dr Miroslav Reljanovic had acquired a total of 200,000 ordinary shares in the AIM-listed biotechnology firm.
Director dealings: Burberry CFO ups stake
Burberry revealed on Monday that chief operating officer and financial officer Julie Brown had acquired 24,051 ordinary shares in the iconic British fashion outfit.
Directors deals: Dixons Carphone's entire board buys in near nine-year lows
The entire board of Dixons Carphone picked up some shares in the electronics retailer at the end of the week.
Director dealings: Evraz's chairman and CEO both sell shares
Evraz's chairman and chief executive officer reduced their stakes in the company just four days after shares of the steelmaker had notched-up fresh record highs.
Director dealings: Burberry's Frasch picks up shares near 200-week moving average
Burberry non-executive director Ron Frasch purchased 456 American Depositary Receipts in the luxury fashion retailer on 17 June.
Director dealings: Oakley Capital co-founder significantly ups stake
Oakley Capital Investments revealed on Tuesday that co-founder Peter Dubens had acquired 5. 33m ordinary shares in the AIM-listed financial services outfit.
Director dealings: Segro CFO lowers stake
Segro revealed on Monday that chief financial officer Soumen Das sold 110,000 ordinary shares in the FTSE 100-listed real estate investment trust.
Director dealings: SolGold CEO's foundation sells shares
SolGold revealed on Friday that The Mather Foundation, a philanthropic auxiliary foundation trust fund of which its chief executive Nicholas Mather was a director, had disposed of 400,000 ordinary shares in the London-listed miner.
Director dealings: Polymetal chairman ups stake
Polymetal revealed on Thursday that chairman Ian Cockerill had acquired 6,800 ordinary shares in the FTSE 250-listed miner.
Director dealings: Scapa CEO ups stake
Scapa Group revealed on Wednesday that chief executive Heejae Chae had acquired 109,700 ordinary shares in the AIM-listed healthcare and industrials company.
Director dealings: 3i executive lowers stake
3i Group general counsel and company secretary Kevin Dunn disposed of 33,508 ordinary shares in the FTSE 100 private equity and venture capital company on Monday.
Director dealings: Sirius Real Estate CEO lowers stake
Sirius Real Estate revealed on Monday that chief executive Andrew Coombs had disposed of 990,000 ordinary shares in the London-listed outfit.
Director dealings: BT CEO snaps up shares
BT revealed on Friday that new chief executive Philp Jansen had acquired 1. 48m ordinary shares in the FTSE 100-listed telco giant.
Director dealings: Pets At Home CEO offloads shares
Pets At Home revealed on Thursday that chief executive Peter Pritchard had disposed of 23,683 ordinary shares in the FTSAE 250-listed retailer.
Director dealings: Greencoat UK Wind director snaps up shares
Greencoat UK Wind revealed on Wednesday that non-executive director Dan Badger had acquired 75,188 ordinary shares in the FTSE 250-listed investment company.
Director dealings: Wentworth Resources CEO makes share purchase
Wentworth Resources revealed on Tuesday that chief executive Eskil Jersing had acquired 265,097 ordinary shares in the AIM-listed gas production and exploration outfit.
Director dealings: Yourgene chairman raises stake
Yourgene Health revealed on Monday that chairman Adam Reynolds had acquired 900,000 ordinary shares in the AIM-listed molecular diagnostics outfit.